PAPER Massimi L, Pieroni N, Maugeri L, Fratini M, Brun F, Bukreeva I, Santamaria G, Medici V, Poloni TE, Balducci C, Cedola A
SEARCH RESULTS
16524 RESULTS
PAPER Switzer AR, Cheema I, McCreary CR, Zwiers A, Charlton A, Alvarez-Veronesi A, Sekhon R, Zerna C, Stafford RB, Frayne R, Goodyear BG, Smith EE
Cerebrovascular reactivity in cerebral amyloid angiopathy, Alzheimer disease, and mild cognitive impairment.
Neurology. 2020 Sep 8;95(10):e1333-e1340. Epub 2020 Jul 8 PubMed: 32641520PAPER Schumacher J, Taylor JP, Hamilton CA, Firbank M, Cromarty RA, Donaghy PC, Roberts G, Allan L, Lloyd J, Durcan R, Barnett N, O'Brien JT, Thomas AJ
Quantitative EEG as a biomarker in mild cognitive impairment with Lewy bodies.
Alzheimers Res Ther. 2020 Jul 8;12(1):82. PubMed: 32641111PAPER Montero-Odasso M, Ismail Z, Livingston G
One third of dementia cases can be prevented within the next 25 years by tackling risk factors. The case "for" and "against".
Alzheimers Res Ther. 2020 Jul 8;12(1):81. PubMed: 32641088PAPER Nakanishi H, Nonaka S, Wu Z
Microglial Cathepsin B and Porphyromonas gingivalis Gingipains as Potential Therapeutic Targets for Sporadic Alzheimer's Disease.
CNS Neurol Disord Drug Targets. 2020;19(7):495-502. PubMed: 32640970PAPER Kumar R, Gulati M, Singh SK, Sharma D, Porwal O
Road From Nose to Brain for Treatment of Alzheimer: The Bumps and Humps.
CNS Neurol Disord Drug Targets. 2020 Jul 8; PubMed: 32640969PAPER Farkhondeh T, Khan H, Aschner M, Samini F, Pourbagher-Shahri AM, Aramjoo H, Roshanravan B, Hoyte C, Mehrpour O, Samarghandian S
Impact of Cannabis-Based Medicine on Alzheimer's Disease by Focusing on the Amyloid β-Modifications: A Systematic Study.
CNS Neurol Disord Drug Targets. 2020;19(5):334-343. PubMed: 32640965PAPER Santaniello A, Garzillo S, Amato A, Sansone M, Di Palma A, Di Maggio A, Fioretti A, Menna LF
Animal-Assisted Therapy as a Non-Pharmacological Approach in Alzheimer's Disease: A Retrospective Study.
Animals (Basel). 2020 Jul 6;10(7) PubMed: 32640648PAPER Schreiber S, DiFrancesco JC
Impaired occipital cerebrovascular reactivity as a biomarker for vascular β-amyloid.
Neurology. 2020 Sep 8;95(10):415-416. Epub 2020 Jul 8 PubMed: 32641536PAPER Yim D, Yeo TY, Park MH
Mild cognitive impairment, dementia, and cognitive dysfunction screening using machine learning.
J Int Med Res. 2020 Jul;48(7):300060520936881. PubMed: 32644870PAPER Fong ZH, Tan SH, Mahendran R, Kua EH, Chee TT
Arts-based interventions to improve cognition in older persons with mild cognitive impairment: A systematic review of randomized controlled trials.
Aging Ment Health. 2020 Jul 8;:1-13. PubMed: 32643397PAPER Chen SJ, Lee BC, Lee NC, Chien YH, Hwu WL, Lin CH
Clinical, radiological, and genetic characteristics in patients with Huntington's disease in a Taiwanese cohort.
Am J Med Genet B Neuropsychiatr Genet. 2020 Sep;183(6):352-359. Epub 2020 Jul 9 PubMed: 32643304PAPER Song D, Yu DS, Sun Q, He G
Correlates of Sleep Disturbance among Older Adults with Mild Cognitive Impairment: A Cross-Sectional Study.
Int J Environ Res Public Health. 2020 Jul 6;17(13) PubMed: 32640633Wim Annaert on γ-Secretase Spotted Traveling Solo or in Pairs, Not in Big Groups
COMMENT Of note, our study focused on the distribution of γ-sec specifically at the cell surface. This should be the site where both ADAM-10 shedding and intramembrane proteolysis by γ-sec preferentially occurs, whereas for BACE1 and γ-sec this should be endosoma
Patrick Fraering on γ-Secretase Spotted Traveling Solo or in Pairs, Not in Big Groups
COMMENT This is an interesting, very well conducted, and solid study using super-resolution microscopy to visualize the spatial and regional distribution and dynamics of individual γ-secretase particles in membranes of living fibroblasts. This challenging task co
Current Filters
- Date Range : Jul 2019 to Jul 2020 x